Simplex Trading’s Lyell Immunopharma LYEL Stock Holding History

Simplex Trading’s Portfolio LYEL Stock Details LYEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.02K	Sell	400 -900	-69%	-$21K	﹤0.01%	7548
2025 Q4	$40K	Hold	1,300	–	–	﹤0.01%	5862
2025 Q3	$21K	Buy	1,300 +1,000	+333%	+$11.4K	﹤0.01%	7290
2025 Q2	$2K	Buy	+300	New	+$2.73K	﹤0.01%	8159
2024 Q3	–	Sell	-115	Closed	-$3K	–	9111
2024 Q2	$3K	Buy	115 +65	+130%	+$3.09K	﹤0.01%	8125
2024 Q1	$2K	Buy	+50	New	+$2.14K	﹤0.01%	8418
2023 Q4	–	Sell	-50	Closed	-$1K	–	9396
2023 Q3	$1K	Buy	+50	New	+$2.37K	﹤0.01%	8351
2022 Q3	–	Sell	-350	Closed	-$45K	–	10484
2022 Q2	$45K	Buy	350 +50	+17%	+$5.11K	﹤0.01%	6647
2022 Q1	$30K	Buy	300 +100	+50%	+$12.1K	﹤0.01%	7768
2021 Q4	$30K	Buy	+200	New	+$44.6K	﹤0.01%	7901

Other funds holding LYEL

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

GSK plc London $599M AUM

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

OPL

Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Simplex Trading's LYEL Position: Q1 2026 in Review

Simplex Trading increased its Lyell Immunopharma (LYEL) stake by 1,773% in Q1 2026, buying an estimated $15.3K and bringing the position to 693 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #7057.

Simplex Trading first reported a position in LYEL in Q4 2021 and has held it in 13 quarters since. The position peaked at $22K in Q2 2022. 74 funds tracked by Wall St. Rank hold LYEL as of Q1 2026.

Simplex Trading held 693 shares of Lyell Immunopharma worth $13.9K as of Q1 2026.
Simplex Trading bought 656 Lyell Immunopharma shares in Q1 2026, an estimated $15.3K.
Lyell Immunopharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7057 holding.
Simplex Trading first reported a position in Lyell Immunopharma in Q4 2021 and has held it in 13 quarters since.
Simplex Trading's Lyell Immunopharma position peaked at $22K in Q2 2022.
74 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.